Tech Company Financing Transactions

Walking Fish Therapeutics Funding Round

Walking Fish Therapeutics secured a $50 million Series A funding round on 9/14/2021. Investors included Emerson Collective, Illumina Ventures and Quan Capital.

Transaction Overview

Company Information

Company Status

Private & Independent

Industry

Biopharmaceutical

Mailing Address

280 Utah Ave. 250
San Francisco, CA 94080
USA

Phone

(650) 392-0422

Website

www.walkingfishtx.com

Email Address

[email protected]

Overview

Walking Fish has created a broad B cell platform for oncology, regenerative medicine, autoimmune disease, and recombinant antibody production. As a leader in B cell engineering, Walking Fish has made critical advances in engineering technologies and has a deep understanding of B cell biology.

Profile

Social Media

Company News

Facebook

YouTube

Management Team

Title

Name

Email & Social

Chief Executive Officer

Lewis Williams

        

Chief Medical Officer

Angela Shen

        

Co-Founder

Tom Brennan

        

Co-Founder

Seenu Kothakota

        

Vice President

Thomas Brennan

        

Vice President

Mark Selby

        

VP - Bus. Development

Seenu Kothakota

        

VP - R & D

Kathleen Boyle

        

Browse more venture capital transactions:

Prev: 9/14/2021: Vividly venture capital transaction
Next: 9/14/2021: SpotOn venture capital transaction

Share this article

Where The Data Comes From

Our team works diligently to document tech company VC transactions. VC investment data records reported here are sourced from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary